MJ Ratain

2.7k total citations
34 papers, 2.0k citations indexed

About

MJ Ratain is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, MJ Ratain has authored 34 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Genetics and 9 papers in Pathology and Forensic Medicine. Recurrent topics in MJ Ratain's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (5 papers). MJ Ratain is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (5 papers). MJ Ratain collaborates with scholars based in United States, Canada and Netherlands. MJ Ratain's co-authors include Rosemarie Mick, Timothy M. Lestingi, Everett E. Vokes, E Gupta, Jesús Ramı́rez, JW Vardiman, MM Le Beau, HM Golomb, Richard A. Larson and E. Vokes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

MJ Ratain

33 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MJ Ratain United States 17 877 828 471 387 269 34 2.0k
Roxanne C. Jewell United States 22 608 0.7× 1.1k 1.3× 251 0.5× 259 0.7× 286 1.1× 59 1.8k
François Lokiec France 30 1.8k 2.1× 1.3k 1.5× 522 1.1× 168 0.4× 200 0.7× 143 3.3k
Christer Paul Sweden 28 1.2k 1.4× 984 1.2× 754 1.6× 264 0.7× 93 0.3× 89 2.4k
B A Chabner United States 24 1.0k 1.2× 1.1k 1.3× 269 0.6× 177 0.5× 359 1.3× 46 2.8k
Peter Hellemans Belgium 20 552 0.6× 533 0.6× 272 0.6× 381 1.0× 363 1.3× 57 1.4k
Adedigbo A. Fasanmade United States 19 610 0.7× 394 0.5× 295 0.6× 274 0.7× 162 0.6× 46 3.4k
Sham Mailankody United States 30 1.3k 1.5× 1.6k 2.0× 1.4k 3.1× 270 0.7× 179 0.7× 147 3.3k
John K. Leighton United States 18 670 0.8× 463 0.6× 424 0.9× 270 0.7× 65 0.2× 34 1.6k
Kapil Dhingra United States 24 763 0.9× 1.2k 1.4× 242 0.5× 122 0.3× 687 2.6× 63 2.9k
Maja J.A. de Jonge Netherlands 33 1.7k 1.9× 1.5k 1.8× 188 0.4× 177 0.5× 219 0.8× 107 3.1k

Countries citing papers authored by MJ Ratain

Since Specialization
Citations

This map shows the geographic impact of MJ Ratain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MJ Ratain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MJ Ratain more than expected).

Fields of papers citing papers by MJ Ratain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MJ Ratain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MJ Ratain. The network helps show where MJ Ratain may publish in the future.

Co-authorship network of co-authors of MJ Ratain

This figure shows the co-authorship network connecting the top 25 collaborators of MJ Ratain. A scholar is included among the top collaborators of MJ Ratain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MJ Ratain. MJ Ratain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Psotka, Mitchell A., Eric R. Gamazon, Tomomitsu Hirota, et al.. (2019). Two Polymorphic Gene Loci Associated with Treprostinil Dose in Pulmonary Arterial Hypertension. The Journal of Heart and Lung Transplantation. 38(4). S208–S208.
2.
Yee, Sook Wah, Yukihide Momozawa, Yoichiro Kamatani, et al.. (2016). Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network‐RIKEN (PGRN‐RIKEN) Collaboration. Clinical Pharmacology & Therapeutics. 100(5). 423–426. 5 indexed citations
3.
Ratain, MJ, et al.. (2009). Biomarkers in Early Cancer Drug Development: Limited Utility. Clinical Pharmacology & Therapeutics. 85(2). 134–135. 15 indexed citations
4.
Conti, Rena M., et al.. (2008). Nonprofit Biomedical Companies. Clinical Pharmacology & Therapeutics. 84(2). 194–197. 5 indexed citations
5.
Gelmon, Karen A., Elizabeth A. Eisenhauer, Adrian L. Harris, MJ Ratain, & Paul Workman. (1999). Anticancer Agents Targeting Signaling Molecules and Cancer Cell Environment: Challenges for Drug Development?. JNCI Journal of the National Cancer Institute. 91(15). 1281–1287. 148 indexed citations
6.
Gupta, E, Rosemarie Mick, Jesús Ramı́rez, et al.. (1997). Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.. Journal of Clinical Oncology. 15(4). 1502–1510. 153 indexed citations
7.
Ratain, MJ, et al.. (1997). New phase I trial methodology.. PubMed. 24(2). 253–61. 9 indexed citations
8.
Gupta, E, Timothy M. Lestingi, Rosemarie Mick, et al.. (1994). Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.. PubMed. 54(14). 3723–5. 409 indexed citations
9.
Schilsky, Richard L., et al.. (1993). Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.. PubMed. 53(6). 1293–6. 3 indexed citations
10.
Mick, Rosemarie & MJ Ratain. (1993). Model-Guided Determination of Maximum Tolerated Dose in Phase I Clinical Trials: Evidence for Increased Precision. JNCI Journal of the National Cancer Institute. 85(3). 217–223. 48 indexed citations
11.
Miller, Carole B., Leonidas C. Platanias, Mariana L. Zahurak, et al.. (1992). Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia. JNCI Journal of the National Cancer Institute. 84(2). 98–103. 73 indexed citations
12.
Platanias, Leonidas C., Carole B. Miller, Ronald D. Hart, et al.. (1991). Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients.. Journal of Clinical Oncology. 9(11). 2021–2026. 91 indexed citations
13.
14.
15.
Mick, Rosemarie, MJ Ratain, & H M Golomb. (1990). Duration of response after interferon treatment of hairy cell leukemia [letter; comment]. Blood. 75(12). 2465–2467. 1 indexed citations
16.
Golomb, H M, MJ Ratain, & Jill Moormeier. (1989). What is the choice of treatment for hairy cell leukemia?. Journal of Clinical Oncology. 7(2). 156–158. 6 indexed citations
17.
Vogelzang, N. J., et al.. (1987). A programmable and implantable pumping system for systemic chemotherapy: a performance analysis in 52 patients.. Journal of Clinical Oncology. 5(12). 1968–1976. 6 indexed citations
18.
Ratain, MJ & Vogelzang Nj. (1987). Limited sampling model for vinblastine pharmacokinetics.. PubMed. 71(10). 935–9. 47 indexed citations
19.
Ratain, MJ, et al.. (1987). Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.. PubMed. 1(4). 340–3. 6 indexed citations
20.
Ratain, MJ, HM Golomb, JW Vardiman, et al.. (1985). Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 65(3). 644–648. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roxanne C. Jewell Breakdown of academic impact, for papers by François Lokiec Breakdown of academic impact, for papers by Christer Paul Breakdown of academic impact, for papers by B A Chabner Breakdown of academic impact, for papers by Peter Hellemans Breakdown of academic impact, for papers by Adedigbo A. Fasanmade Breakdown of academic impact, for papers by Sham Mailankody Breakdown of academic impact, for papers by John K. Leighton Breakdown of academic impact, for papers by Kapil Dhingra Breakdown of academic impact, for papers by Maja J.A. de Jonge
Rankless by CCL
2026